Author:
Cai Zeqiong,Bai Han,Ren Doudou,Xue Biyun,Liu Yijia,Gong Tian,Zhang Xuan,Zhang Peng,Zhu Junsheng,Shi Binyin,Zhang Chengsheng
Funder
Nanchang University
Science and Technology Department of Sichuan Province
Xi’an Jiaotong University
Subject
Cancer Research,Infectious Diseases,Virology
Reference55 articles.
1. Covid-19 in a patient with multiple sclerosis treated with natalizumab: may the blockade of integrins have a protective role?;Aguirre;Mult. Scler. Relat. Disord.,2020
2. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice;Amruta;Life Sci.,2021
3. Andrews, M.G., Mukhtar, T., Eze, U.C., Simoneau, C.R., Perez, Y., Mostajo-Radji, M.A., Wang, S., Velmeshev, D., Salma, J., Kumar, G.R., Pollen, A.A., Crouch, E.E., Ott, M., Kriegstein, A.R., 2021. Tropism of SARS-CoV-2 for developing human cortical astrocytes. bioRxiv: the preprint server for biology.
4. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells;Arthos;Nat. Immunol.,2008
5. The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection;Beddingfield;JACC. Basic Transl. Sci.,2021